Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
about
Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight ratsHepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver.Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.Serotonergic Control of Metabolic Homeostasis.The effect of serotonin reuptake inhibitors on hepatic injury induced by carbon tetrachloride
P2860
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
@en
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
@nl
type
label
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
@en
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
@nl
prefLabel
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
@en
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
@nl
P2093
P2860
P1476
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
@en
P2093
Alan D Cherrington
Ben Farmer
Doss W Neal
Jason J Winnick
Margaret Lautz
Marta Smith
Mary C Moore
Tiffany Rodewald
P2860
P304
P356
10.1016/J.EJPHAR.2009.01.042
P407
P577
2009-04-01T00:00:00Z